Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource

Imatinib mesylate

HealthData.Gov

Updated Jul 6, 2026

About this dataset

Imatinib Mesylate is a generic prescription oral tablet medication that inhibits certain enzymes to treat conditions like chronic myeloid leukemia and gastrointestinal stromal tumors. Available in 100mg and 400mg strengths from Chartwell RX, LLC, it was approved under ANDA208429 and first marketed in 2019. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Imatinib mesylate

    Access the FDA dataset for Imatinib mesylate β€” ANDA 203308 submitted by Mylan Institutional LLC

    Modified Dec 27, 2025

Prototype by Datopian Β· not an official government website Β· data from data.virginia.gov